When does Straumann report earnings and how might that affect STMN.SW stock?

Straumann reports after the market on 18 Feb 2026. The STMN.SW stock often reacts to revenue mix, implant volumes and margin guidance; better-than-expected top-line or margins could push shares above CHF100.00, while misses may widen the downside to near CHF88.97.

What valuation metrics should investors watch for STMN.SW stock?

Key metrics are PE **36.62**, price-to-sales **6.09**, return on equity **19.17%**, and free cash flow yield **2.24%**. These show premium pricing versus Healthcare peers and highlight sensitivity to earnings and cash flow changes for STMN.SW stock.

What is Meyka AI's short-term and 12-month view on STMN.SW stock?

Meyka AI's model projects a monthly estimate **CHF88.97** and a 12-month target **CHF100.52**, implying **-9.68%** near-term risk and **+2.06%** upside over 12 months. These are model outputs and not guarantees.

CH Stocks

Straumann (STMN.SW, SIX) pre-market CHF98.50 13 Feb 2026: earnings set tone

ByHuzaifa Zahoor February 13, 2026

We open pre-market on 13 Feb 2026 with Straumann Holding AG (STMN.SW) at CHF98.50, and the company’s upcoming earnings on 18 Feb 2026 are the near-term catalyst for the STMN.SW stock. The shares trade on SIX with a PE of 36.62 and volume 364,953, while the 50-day average is CHF95.65. Investors will watch revenue growth, margin trends and guidance for signs the Healthcare sector recovery is broadening.